Recent Advances in Peripheral Artery Disease
A special issue of Hearts (ISSN 2673-3846).
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 4247
Special Issue Editor
Interests: molecular and cellular mechanisms of angiogenesis and vasculogenesis; use of angiogenic growth factors for therapeutic angiogenesis and tissue regeneration; diabetes complications; genetics of cardiovascular and neurodegenerative diseases
Special Issue Information
Dear Colleagues,
Peripheral artery disease (PAD) is an increasingly important clinical problem. Years after its first description, it is now clear that PAD is not a simple complication of other diseases such as diabetes or arterial hypertension, but an independent and relevant cardiovascular risk factor. In addition to its effect on patients, PAD can have a significant impact on healthcare systems as it increases with age and leads to cardiovascular complications. The quality of life and survival rate of patients with PAD are low compared to other patients. Unfortunately, until recently, all available data on designing treatments for patients with PAD were overshadowed by studies conducted in other patient populations and other outcomes. Opportunely, PAD has been the focus of many high-quality studies in recent years, and more useful and valid data are available for the treatment of this severe disease.
The purpose of this Special Issue is to collect original research studies and literature reviews that will provide a better understanding of PAD and newer treatment strategies.
Dr. Federico Biscetti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Hearts is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- peripheral artery disease (PAD)
- critical limb threatening ischemia (CLTI)
- cardiovascular complications of diabetes
- type 2 diabetes mellitus
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
